drugset
drugset / Trial / NCT04429893

Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy

NCT04429893 ↗

Phase 2/3 Unknown 80 enrolled Alexandria University
RandomizedParallel-groupDouble-blindSupportive care

Summary

Modified radical mastectomy may be associated with severe post-operative pain, leading to chronic pain syndrome which usually requires optimal perioperative pain management.

Timeline

Start
2022-01-01
Primary completion
2022-09
Completion
2022-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 150 mg —
Background Bupivacaine Other / unclassified 0.5 % —
Background Bupivacaine Other / unclassified 20 ml —

Indications

breast cancer chronic pain syndrome